Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapies
Abstract Endocrine therapy (ET) is recommended as first-line therapy for the majority of patients with hormone receptor-positive (HR+), human epidermal growth factor 2-negative advanced breast cancer (ABC); however, the efficacy of ET in patients with visceral metastases (VM) versus patients whose d...
Guardado en:
Autores principales: | John F. R. Robertson, Angelo Di Leo, Stephen Johnston, Stephen Chia, Judith M. Bliss, Robert J. Paridaens, Jasmine Lichfield, Ian Bradbury, Christine Campbell |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d7d894e65aa140f485dd6e6e9833028a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Metastatic melanoma with sebocyte-like melanocytes and widespread visceral involvement
por: Li-Wei Chang, et al.
Publicado: (2020) -
Larva Migrans Visceral
por: Aldunate G,Diego, et al.
Publicado: (1983) -
Phase II trail of nab-paclitaxel in metastatic breast cancer patients with visceral metastases
por: Yizhao Xie, et al.
Publicado: (2021) -
Diagnosis of human visceral pentastomiasis.
por: Dennis Tappe, et al.
Publicado: (2009) -
Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women.
por: Caroline S Fox, et al.
Publicado: (2012)